Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Microbiota as a biomarker of tuberculosis treatment response: association with clinical history, inflammation and outcome. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2025 · External reference
Unresolved reference
2025 · External reference
Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis
10.1016/j.ebiom.2021.103374 · 2021 · External reference
Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis
10.1038/s41467-021-21475-y · 2021 · External reference
Increased risk of childhood asthma from antibiotic use in early life
10.1378/chest.06-3008 · 2007 · External reference
Antibiotic exposure in early life increases risk of childhood obesity: a systematic review and meta-analysis
10.3389/fendo.2017.00170 · 2017 · External reference
The effect of past antibiotic exposure on diabetes risk
10.1530/eje-14-1163 · 2015 · External reference
Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice
10.1038/nmicrobiol.2016.140 · 2016 · External reference
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy
10.1186/s40168-017-0286-2 · 2017 · External reference
Gut microbiota composition and diversity before, during, and two months after rifamycin-based tuberculosis preventive therapy
10.1038/s41598-023-44854-5 · 2023 · External reference
Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota
10.1371/journal.pntd.0008230 · 2020 · External reference
Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy
10.1038/s41598-021-04271-y · 2021 · External reference
Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
10.1038/s41598-017-10346-6 · 2017 · External reference
T reg induction by a rationally selected mixture of Clostridia strains from the human microbiota
10.1038/nature12331 · 2013 · External reference
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
10.1016/s2213-2600(19)30370-4 · 2020 · External reference
Unresolved reference
External reference
Subtracting the background by reducing cell-free DNA's confounding effects on Mycobacterium tuberculosis quantitation and the sputum microbiome
10.1038/s41598-024-73497-3 · 2024 · External reference
Conducting a microbiome study
10.1016/j.cell.2014.06.037 · 2014 · External reference
The vegan package
2007 · External reference
Unresolved reference
2010 · External reference
10.1201/9781315370279
10.1201/9781315370279 · 2017 · External reference
Unresolved reference
External reference
Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis
10.1183/09031936.00151413 · 2014 · External reference
Molecular markers of early immune response in tuberculosis: prospects of application in predictive medicine
10.3390/ijms241713261 · 2023 · External reference
Unresolved reference
2023 · External reference
Unresolved reference
2013 · External reference
Unresolved reference
2013 · External reference
Bead-based multiplex immuno-assays for cytokines, chemokines, growth factors and other analytes: Median fluorescence intensities versus their derived absolute concentration values for statistical analysis
10.1016/j.cyto.2014.10.030 · 2015 · External reference
microViz: an R package for microbiome data visualization and statistics
10.21105/joss.03201 · 2021 · External reference
Alveolar microbiota profile in patients with human pulmonary tuberculosis and interstitial pneumonia
10.1016/j.micpath.2019.103851 · 2020 · External reference
Impact of tuberculosis disease on human gut microbiota: a systematic review
10.1080/14787210.2023.2162879 · 2023 · External reference
Excess fermentation and lactic acidosis as detrimental functions of the gut microbes in treatment-naive TB patients
10.3389/fcimb.2024.1331521 · 2024 · External reference
Bacteria as vitamin suppliers to their host: a gut microbiota perspective
10.1016/j.copbio.2012.08.005 · 2013 · External reference
Regulation of short-chain fatty acid production
10.1079/pns2002207 · 2003 · External reference
The nonpathogenic commensal Neisseria: friends and foes in infectious disease
10.1097/qco.0000000000000585 · 2019 · External reference
Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE)
10.1007/s12088-022-01003-2 · 2022 · External reference
Metabolic and immune consequences of antibiotic related microbiome alterations during first-line tuberculosis treatment in Bamako, Mali
2025 · External reference
Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular
10.1128/aac · 2018 · External reference
Brief report: dialister as a microbial marker of disease activity in spondyloarthritis
10.1002/art.39802 · 2017 · External reference
DOP08 Deep remission in paediatric Crohn’s disease is associated with increased abundance of dialister species and increased valerate
10.1093/ecco-jcc/jjz203.047 · 2020 · External reference
Gut mucosal microbiota profiles linked to colorectal cancer recurrence
10.3748/wjg.v28.i18.1946 · 2022 · External reference
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
10.1073/pnas.1000087107 · 2011 · External reference
Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis
10.1016/j.ijid.2012.07.013 · 2012 · External reference
Inflammation responses in patients with pulmonary tuberculosis in an intensive care unit
2018 · External reference
Systemic Levels of Pro-Inflammatory Cytokines and Post-Treatment Modulation in Tuberculous Lymphadenitis
10.3390/tropicalmed8030150 · 2023 · External reference
Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis
10.1177/03000605211036832 · 2021 · External reference
Unresolved reference
2022 · External reference
Matrix metalloproteinases and tissue inhibitors of metalloproteinases are potential biomarkers of pulmonary and extra-pulmonary tuberculosis
10.3389/fimmu.2020.00419 · 2020 · External reference
Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis
10.1093/ofid/ofz257 · 2019 · External reference
Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results
10.3390/pathogens10070789 · 2021 · External reference
Changes of C-reactive protein and Procalcitonin after four weeks of treatment in patients with pulmonary TB
10.1016/j.jctube.2023.100348 · 2023 · External reference
Unresolved reference
2015 · External reference
Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients
10.1007/s15010-022-01870-3 · 2023 · External reference
Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
10.1186/s12879-018-3246-y · 2018 · External reference
Unresolved reference
2008 · External reference
Four-month rifapentine regimens with or without moxifloxacin for tuberculosis
10.1056/nejmoa2033400 · 2021 · External reference
Treatment strategy for rifampin-susceptible tuberculosis
10.1056/nejmoa2212537 · 2023 · External reference
